News & Updates

Thiazolidinedione reduces mortality, adverse events in T2D patients with AKD

Treatment with thiazolidinedione (TZD) results in a significant decrease in mortality, cardiovascular events, and kidney-related adverse events among type 2 diabetes (T2D) patients with acute kidney disease (AKD), a recent study has shown.

The Philippines’ father of endocrinology cannot be stopped

Back in the ‘60s, something was bothering a younger Dr Augusto D. Litonjua. Landing back in Manila enlightened by Harvard mentors, he realized there was no networking among endocrinology-leaning local practitioners, much less any organization, for that matter.

StrongHER, TogetHER: A comprehensive review of obstetrical dilemma in endometriosis and infertility

Belantamab mafodotin, bortezomib, dexamethasone triplet scores big in RRMM

Triplet therapy with belantamab mafodotin, bortezomib, and dexamethasone (BVd) significantly improves outcomes in relapsed or refractory multiple myeloma (RRMM), outperforming the daratumumab, bortezomib, and dexamethasone (DVd) combination therapy, according to the second interim analysis of the phase III DREAMM-7 trial.

Disease-related brain activation forecasts TNF inhibitor response in RA

In patients with rheumatoid arthritis (RA), high disease-associated central nervous system (CNS) pain activation on functional MRI (fMRI) brain scan may help predict clinical response to TNF inhibitor treatment, as shown in a phase III study.

Haemoglobin levels after childbirth may flag postpartum depression

New research in women with vaginal births has found a significant association between haemoglobin levels immediately after childbirth and the likelihood of developing symptoms of postpartum depression (PPD).

Children with ALL suffer drug therapy problems

Drug therapy problems (DTPs), such as adverse drug reactions (ADRs), remain highly prevalent in children with acute lymphoblastic leukaemia (ALL), a study has found.

Is radiologic imaging necessary in cutaneous SCC?

Radiologic imaging of high-risk cutaneous squamous cell carcinoma (sSCC) tumours displays unforeseen results such as local invasion and nodal metastasis, which result in changes in management in nearly half of these cases, reveals a study.

Abrocitinib, dupilumab restore skin barrier function in AD

Treatment with abrocitinib or dupilumab results in the restoration of skin barrier function in patients with atopic dermatitis (AD), but these therapies show distinct proteomic impacts, according to a study.